home / United States / Dynavax Technologies

Dynavax Technologies Market Cap

$1.65 B

-0.01 B

NASDAQ:DVAX · January 22, 2025

Share price

$12.57

Enterprise Value

$1.16 B

Change (1-Year)

-12.7%

Global Rank

#4454

Country Rank

#1656

Regions

USA

Market cap

As of January 22, 2025, Dynavax Technologies (DVAX) has a market cap of $1.65 billion USD. According to our data, Dynavax Technologies is ranked No.4454 in global market value.

Sector Rank:

Biotech #228 Pharmaceuticals #209

DVAX Market Capitalization Growth

30D Growth:

-3.0%

1 Years Growth:

-12.7%

3 Years Growth:

-1.2%

5 Years Growth:

116.9%

10 Years Growth:

-29.0%

15 Years Growth:

-16.4%

20 Years Growth:

-83.0%

Total Growth:

-86%

Dynavax Technologies Market Cap Chart

YTD

10Y

15Y

20Y

MAX

Dynavax Technologies Market Cap CAGR Chart

Dynavax Technologies Market Cap History 2004 - 2025

Year	Market Cap	%Change
Jan 22, 2025	$1.65 B	-1.54%
Dec 31, 2024	$1.68 B	-8.66%
Dec 29, 2023	$1.84 B	31.39%
Dec 30, 2022	$1.40 B	-24.38%
Dec 31, 2021	$1.85 B	216.18%
Dec 31, 2020	$0.58 B	-22.20%
Dec 31, 2019	$0.75 B	-37.49%
Dec 31, 2018	$1.20 B	-51.07%
Dec 29, 2017	$2.46 B	373.42%
Dec 30, 2016	$0.52 B	-83.65%
Dec 31, 2015	$3.18 B	43.30%
Dec 31, 2014	$2.22 B	-13.98%
Dec 31, 2013	$2.58 B	-31.23%
Dec 31, 2012	$3.75 B	-14.16%
Dec 30, 2011	$4.36 B	3.75%
Dec 31, 2010	$4.21 B	125.35%
Dec 31, 2009	$1.87 B	69.05%
Dec 31, 2008	$1.10 B	-83.56%
Dec 31, 2007	$6.72 B	-44.34%
Dec 29, 2006	$12.07 B	118.05%
Dec 30, 2005	$5.53 B	-47.38%
Dec 31, 2004	$10.52 B	100%

Similar Companies to Dynavax Technologies

Name	Market Cap	Market cap difference	Regions
Moderna MRNA	$14.82 B	-0.000 M	USA
BioNTech BNTX	$27.61 B	0.000 M	Germany
Novavax NVAX	$1.41 B	-0.000 M	USA
Santander SAN	$74.07 B	0.604 B	Spain
Pfizer PFE	$147.43 B	0.004 M	USA
AstraZeneca AZN	$211.49 B	0.007 M	UK
Johnson & Johnson JNJ	$349.71 B	-0.006 M	USA
Merck MRK	$242.01 B	0.005 M	USA
GlaxoSmithKline GSK	$68.21 B	-0.002 M	UK
Regeneron Pharmaceuticals REGN	$74.73 B	1.236 B	USA
Eli Lilly LLY	$677.80 B	-0.006 M	USA
AbbVie ABBV	$298.91 B	0.013 M	USA
Bristol-Myers Squibb BMY	$115.77 B	0.000 M	USA
Amgen AMGN	$146.98 B	0.004 M	USA

About Dynavax Technologies Inc.

Name

Dynavax Technologies Corporatio

Website

https://www.dynavax.com

Headquarters

EmeryVille,CA

symbol

DVAX

CURRENCY

USD

country

United States

fullTimeEmployees

408

exchange

NMS

firstTradeDateEpochUtc

2004/02/19

DVAX Market Cap Formula

Market Cap	=	DVAX Stock Price	*	DVAX Shares Outstanding
	=	$12.57	*	0.13 B
	=	$1.65 B

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe